Tiewei Cheng
Impact in
Papers in
-
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
- Co-authors
- David J. McConkeyBeat RothColin P. DinneyWoonyoung ChoiI-Ling LeeSima P. PortenBogdan CzerniakJonathan Melquist
- Journals
- Molecular Cancer Research (1 paper)Clinical Cancer Research (1 paper)FEBS Letters (1 paper)Oncotarget (1 paper)Antioxidants (1 paper)
- Partner nations
- United StatesSwitzerlandSingapore
In The Last Decade
Tiewei Cheng
12 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Surgery 1.1k
- Urology 116
- Oncology 383
- Cancer Research 178
- Pulmonary and Respiratory Medicine 363
Countries citing papers authored by Tiewei Cheng
This map shows the geographic impact of Tiewei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiewei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiewei Cheng more than expected).
Fields of papers citing papers by Tiewei Cheng
This network shows the impact of papers produced by Tiewei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiewei Cheng. The network helps show where Tiewei Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tiewei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 25 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 6 | |
| 5 | 2018 | 8 | |
| 6 | 2016 | 15 | |
| 7 | 2015 | 28 | |
| 8 | Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy Hit paper breakdown → | 2014 | 1185 |
| 9 | 2013 | 66 | |
| 10 | 2011 | 58 | |
| 11 | 2010 | 26 | |
| 12 | 2007 | 38 |
About Tiewei Cheng
Tiewei Cheng is a scholar working on Hematology, Endocrine and Autonomic Systems, Molecular Biology, Oncology and Genetics, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Urinary and Genital Oncology Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers), Protein Degradation and Inhibitors (2 papers) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Surgery (1.1k citations), Urology (116 citations), Oncology (383 citations), Cancer Research (178 citations) and Pulmonary and Respiratory Medicine (363 citations). Tiewei Cheng has collaborated with scholars based in United States, Switzerland and Singapore. Frequent co-authors include David J. McConkey, Beat Roth, Colin P. Dinney, Woonyoung Choi, I-Ling Lee, Sima P. Porten, Bogdan Czerniak, Jonathan Melquist, Shanna Pretzsch and Shizhen Zhang. Their work appears in journals such as Molecular Cancer Research, Clinical Cancer Research, FEBS Letters, Oncotarget and Antioxidants.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.